The following determinations were done on each sample by a commercial radioimmunoassay (RIA) kit: serum TBG from Hoechst lab, carcinoembryonic antigen (CEA) from CIS lab, resin T3 uptake (RT3U) and 3, 3', 5'-triiodothyronine (rT3) from Dainabot lab, thyroxine (T4) from Eiken lab, 3, 3', Case 1, a patient with gastric cancer, had subtotal gastrectomy on October, 1979. Serum TBG and T4 were at a high level for about 8months and then decreased to the normal range before death (Fig. 2) . Case 3 was operated on for gastric cancer in May, 1980 . Before the operation serum TBG, T4, FT4 and T3 were slightly elevated but normalized after the operation (Fig. 3) . Case 4 had a recurrence of gastric cancer one year after gastrectomy. Increased serum TBG and decreased RT3U continued for 6months until two months before death. Serum T4, T3 and FT4 were always in the normal range (Fig. 4) .
Case 10 was diagnosed as having a cholangioma before death, and had an extremely high CEA level (about 500ng/ml). On autopsy, she was found to have had hepatocellular carcinoma. Hyperthyroxine- Serum TBG and CEA levels were examined in these patients.
There was no relationship between serum TBG and CEA levels. A high TBG was found without any relationship to the CEA level (Fig. 6) 
Discussion
It is well known that serum TBG is affected by a few hormones and a wide variety of diseases. Increased serum TBG during pregnancy is well known Robbins and Nelson., 1958) and this phenomenon is caused by increased serum estrogen inducing increased TBG production in the liver Glinoer et al., 1977) . Estrogen, especially estradiol, is the most active steroid in this respect (Kagedal and Kallberg, 1977) . In the present study we found increased serum TBG in two patients with prostate cancer taking estrogen therapy. Recently, an elevated TBG level in Graves' patients has been reported by Yabu et al., (1980) . In the present study all cancerous patients with a high serum TBG level had neither clinical symptoms of Graves' disease nor anti-thyroidal antibodies.
An acute increase in serum TBG has been reported in infectious hepatitis (Tabei and Shimoda, 1973) . In the present report Case 2 showed increased serum TBG during serum hepatitis after a blood transfusion at the time of total gastrectomy. The TBG level normalized following the improvement of liver function.
In the present study we found increased. Previously Pederson (1974) had reported that hepatocellular carcinoma was occasionally associated with an increase in serum TBG. However, Gershengorn et al. (1976) demonstrated that TBG was far from constant and was not correlated with the The relation between serum TBG and serum CEA was examined in many cancer patients, but no correlation was found (Fig. 6 ).
In the cases followed during a clinical course, serum TBG levels in 3 patients (Case 1, 4 and 10) remained high until just before death. The fall may be due to cachexia in the terminal stage of cancer. The serum TBG level in one patient (Case 3) dropped to normal after an operation on the original gastric cancer. have been reported normal in congenital TBG abnormality (Nikolai and Roberts, 1969) . We deduce that the slightly high FT4 level in the cancer patients may be due to low serum levels of other thyroid hormone binding proteins such as TBPA and albumin, slightly increased serum T4 or methodlogical complexities in determining free T4 accurately.
In the present study we found 8 cases with a high serum TBG level without obvious cause among 169 cancer paitents. Although the incidence of elevation is low (about 4.7% of cancer patients), TBG is useful as a tumor maker in certain cancer ous states.
